विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| अल्सरेटिव कोलाइटिस के लिए मेयो स्कोर× | हार्वे-ब्राडशॉ इंडेक्स (HBI)× | |
|---|---|---|
| क्षेत्र | जठरांत्र विज्ञान | जठरांत्र विज्ञान |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 1987 | 1980 |
| प्रवर्तक≠ | Schroeder, K. W., Tremaine, W. J., and Ilstrup, D. M. | R. F. Harvey and J. M. Bradshaw |
| प्रकार | Clinician-rated | Clinician-rated |
| मौलिक स्रोत≠ | Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625–1629. DOI ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| उपनाम≠ | Mayo Clinic Score, UC Mayo Score | HBI |
| संबंधित≠ | 4 | 5 |
| सारांश≠ | The Mayo Score is a validated tool for assessing disease activity in ulcerative colitis, integrating clinical symptoms and endoscopic findings. Introduced by Schroeder and colleagues in 1987, it has become the reference standard for UC activity assessment in clinical trials and practice. The score combines stool frequency, rectal bleeding, overall physician global assessment, and endoscopic subscore into a single 0–12 scale. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGateडेटासेट ↗ |
|
|